Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 48 Records) |
Query Trace: Microsatellite Instability and NRAS[original query] |
---|
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics. Clinical colorectal cancer 2018 Jul . Khan Maliha, Loree Jonathan M, Advani Shailesh M, Ning Jing, Li Wen, Pereira Allan A L, Lam Michael, Raghav Kanwal, Morris Van K, Broaddus Russell, Maru Dipen, Overman Michael J, Kopetz Sco |
Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study. Head and neck pathology 2018 5 13 (2): 162-168. Stevens Todd M, Morlote Diana, Swensen Jeff, Ellis Michelle, Harada Shuko, Spencer Sharon, Prieto-Granada Carlos N, Folpe Andrew L, Gatalica Zor |
Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients. Oncotarget 2018 May 9 (35): 24081-24096. Sayagués José María, Del Carmen Sofía, Del Mar Abad María, Corchete Luís Antonio, Bengoechea Oscar, Anduaga María Fernanda, Baldeón María Jesús, Cruz Juan Jesús, Alcazar Jose Antonio, Angoso María, González Marcos, García Jacinto, Muñoz-Bellvis Luís, Orfao Alberto, Sarasquete María Eugen |
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer. Journal of the National Cancer Institute 2018 Apr . Loree Jonathan M, Bailey Ann M, Johnson Amber M, Yu Yao, Wu Wenhui, Bristow Christopher A, Davis Jennifer S, Shaw Kenna R, Broaddus Russell, Banks Kimberly C, Lanman Richard B, Meric-Bernstam Funda, Overman Michael J, Kopetz Scott, Raghav Kanw |
Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma. Gastroenterology research and practice 2018 2018 4585802. Liu Jianhua, Zeng Weiqiang, Huang Chengzhi, Wang Junjiang, Yang Dongyang, Ma Do |
Systemic Therapy for Colon Cancer. Surgical oncology clinics of North America 2018 3 27 (2): 235-242. Wu Christi |
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients. Clinical drug investigation 2018 Jun 38 (6): 553-562. Moiseyenko Vladimir M, Moiseyenko Fedor V, Yanus Grigoriy A, Kuligina Ekatherina Sh, Sokolenko Anna P, Bizin Ilya V, Kudriavtsev Alexey A, Aleksakhina Svetlana N, Volkov Nikita M, Chubenko Vyacheslav A, Kozyreva Kseniya S, Kramchaninov Mikhail M, Zhuravlev Alexandr S, Shelekhova Kseniya V, Pashkov Denis V, Ivantsov Alexandr O, Venina Aigul R, Sokolova Tatyana N, Preobrazhenskaya Elena V, Mitiushkina Natalia V, Togo Alexandr V, Iyevleva Aglaya G, Imyanitov Evgeny |
KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician. Radiology and oncology 2019 9 53 (3): 265-274. Afr?sânie Vlad-Adrian, Marinca Mihai Vasile, Alexa-Stratulat Teodora, Gafton Bogdan, P?duraru Marius, Adavidoaiei Anca Maria, Miron Lucian, Rusu Cristi |
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nature communications 2019 8 10 (1): 3722. Serebriiskii Ilya G, Connelly Caitlin, Frampton Garrett, Newberg Justin, Cooke Matthew, Miller Vince, Ali Siraj, Ross Jeffrey S, Handorf Elizabeth, Arora Sanjeevani, Lieu Christopher, Golemis Erica A, Meyer Joshua |
Prognostic and predictive markers in liver limited stage IV colorectal cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 7 45 (12): 2251-2256. Rehman Adeeb H, Jones Robert P, Poston Grae |
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy. Cancer medicine 2019 May . Fleitas-Kanonnikoff Tania, Martinez-Ciarpaglini Carolina, Ayala Josefina, Gauna Cinthia, Denis Rita, Yoffe Ita, Sforza Silvia, Martínez María Teresa, Pomata Alicia, Ibarrola-Villava Maider, Arevshatyan Sipan, Burriel Verónica, Boscá Diego, Pastor Oscar, Ferrer-Martinez Ana, Carrasco Francisca, Mongort Cristina, Navarro Samuel, Ribas Gloria, Cervantes Andr |
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer. Journal of translational medicine 2019 Apr 17 (1): 137. Isnaldi Edoardo, Garuti Anna, Cirmena Gabriella, Scabini Stefano, Rimini Edoardo, Ferrando Lorenzo, Lia Michela, Murialdo Roberto, Tixi Lucia, Carminati Enrico, Panaro Andrea, Gallo Maurizio, Grillo Federica, Mastracci Luca, Repetto Lazzaro, Fiocca Roberto, Romairone Emanuele, Zoppoli Gabriele, Ballestrero Alber |
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Mar JCO1801798. Innocenti Federico, Ou Fang-Shu, Qu Xueping, Zemla Tyler J, Niedzwiecki Donna, Tam Rachel, Mahajan Shilpi, Goldberg Richard M, Bertagnolli Monica M, Blanke Charles D, Sanoff Hanna, Atkins James, Polite Blasé, Venook Alan P, Lenz Heinz-Josef, Kabbarah Om |
Implication of Microsatellite Instability Pathway in Outcome of Colon Cancer in Moroccan Population. Disease markers 2019 12 2019 3210710. El Agy Fatima, Otmani Ihssane El, Mazti Asmae, Lahmidani Nada, Oussaden Abdelmalek, El Abkari Mohamed, Benjelloun El Bachir, Moukit Wadih, El Bouhaddouti Hicham, Toughrai Imane, Hassani Karim Ibn Majdoub, Maazaz Khalid, Benbrahim Zineb, Mellas Nawfal, El Rhazi Karima, Ouldim Karim, El Bardai Sanae, Adil Ibrahimi Sidhi, Ait Taleb Khalid, Bennis Sanae, Laila Chba |
Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer. Oncology letters 2019 Jan 17 (1): 332-338. Niu Wenbo, Wang Guiying, Feng Jun, Li Zheng, Li Chenhui, Shan Bao |
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer. Journal of Cancer 2020 4 11 (13): 3827-3833. Li Weihua, Qiu Tian, Dong Lin, Zhang Fanshuang, Guo Lei, Ying Jianmi |
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists? Journal of clinical pathology 2020 4 73 (11): 741-747. Bourhis Amélie, De Luca Caterina, Cariou Mélanie, Vigliar Elena, Barel Fanny, Conticelli Floriana, Marcorelles Pascale, Nousbaum Jean-Baptiste, Robaszkiewicz Michel, Samaison Laura, Badic Bogdan, Doucet Laurent, Troncone Giancarlo, Uguen Arna |
Relationship between CpG island methylation phenotype, microsatellite instability phenotype and mutation of KRAS, NRAS, and BRAF genes in colorectal cancer. International journal of clinical and experimental pathology 2020 1 12 (3): 1101-1107. Luo Yu, Cheng Bo, Liu Shan, Xu Lin, Wu Xizhao, Sun Suoz |
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial. JAMA oncology 2021 Aug . Martinelli Erika, Martini Giulia, Famiglietti Vincenzo, Troiani Teresa, Napolitano Stefania, Pietrantonio Filippo, Ciardiello Davide, Terminiello Marinella, Borrelli Carola, Vitiello Pietro Paolo, De Braud Filippo, Morano Federica, Avallone Antonio, Normanno Nicola, Nappi Anna, Maiello Evaristo, Latiano Tiziana, Falcone Alfredo, Cremolini Chiara, Rossini Daniele, Santabarbara Giuseppe, Pinto Carmine, Santini Daniele, Cardone Claudia, Zanaletti Nicoletta, Di Liello Alessandra, Renato Daniela, Esposito Lucia, Marrone Francesca, Ciardiello Fortuna |
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials. Journal of cancer research and clinical oncology 2021 Mar . Noepel-Duennebacke Stefanie, Juette Hendrik, Schulmann Karsten, Graeven Ulrich, Porschen Rainer, Stoehlmacher Jan, Hegewisch-Becker Susanna, Raulf Arne, Arnold Dirk, Reinacher-Schick Anke, Tannapfel Aandr |
Histology-based molecular profiling improves mutation detection for advanced thyroid cancer. Genes, chromosomes & cancer 2021 3 60 (8): 531-545. Eszlinger Markus, Khalil Moosa, Gillmor Aaron Hill, Huang Helen, Stewardson Paul, McIntyre John B, Morrissy Sorana, Paschke Ra |
Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer. JCO precision oncology 2022 Mar 6 e2100365. Gularte-Mérida Rodrigo, Smith Shaleigh, Bowman Anita S, da Cruz Paula Arnaud, Chatila Walid, Bielski Craig M, Vyas Monika, Borsu Laetitia, Zehir Ahmet, Martelotto Luciano G, Shia Jinru, Yaeger Rona, Fang Fang, Gardner Rui, Luo Ruibang, Schatz Michael C, Shen Ronglai, Weigelt Britta, Sánchez-Vega Francisco, Reis-Filho Jorge S, Hechtman Jaclyn |
Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition. Scientific reports 2022 02 12 (1): 2570. Jungwirth Jiri, Urbanova Marketa, Boot Arnoud, Hosek Petr, Bendova Petra, Siskova Anna, Svec Jiri, Kment Milan, Tumova Daniela, Summerova Sandra, Benes Zdenek, Buchler Tomas, Kohout Pavel, Hucl Tomas, Matej Radoslav, Vodickova Ludmila, van Wezel Tom, Vodicka Pavel, Vymetalkova Veroni |
Genetic and epigenetic characteristics of patients with colorectal cancer from Uruguay. Pathology, research and practice 2022 12 241 154264. Vital Marcelo, Carusso Florencia, Vergara Carolina, Neffa Florencia, Della Valle Adriana, Esperón Patric |
KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania. Medicine 2022 Oct 101 (40): e30979. Brinzan Costel Stelian, Aschie Mariana, Cozaru Georgeta Camelia, Deacu Mariana, Dumitru Eugen, Burlacu Ionut, Mitroi An |
[Rapid Idylla™ mutational testing: Current and future theranostic applications]. Annales de pathologie 2022 1 42 (4): 329-343. Bourhis Amélie, Remoué Annabelle, Samaison Laura, Uguen Arna |
Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions. Surgery 2022 1 171 (6): 1605-1611. Angriman Imerio, Fassan Matteo, Nacci Camilla, De Simoni Ottavia, Kotsafti Andromachi, Businello Gianluca, Ruffolo Cesare, Scarpa Melania, Dei Tos Angelo Paolo, Agostini Marco, Pucciarelli Salvatore, Bardini Romeo, Scarpa Mar |
Epidemiological and molecular evaluation of BRAF, KRAS, NRAS genes and MSI in the development of colorectal cancer. Gene 2023 3 870 147395. Paula Simedan Vila Ana, Helena Rodrigues Gabriela, Leite Marzochi Ludmila, Garcia de Oliveira-Cucolo Juliana, Lívia Silva Galbiatti-Dias Ana, Felipe Maciel Andrade Rafael, de Santi Neto Dalísio, Gomes Netinho João, Castiglioni Lilian, Cristina Pavarino Érika, Maria Goloni-Bertollo E |
Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study. Cell reports. Medicine 2023 3 100980. Niehues Jan Moritz, Quirke Philip, West Nicholas P, Grabsch Heike I, van Treeck Marko, Schirris Yoni, Veldhuizen Gregory P, Hutchins Gordon G A, Richman Susan D, Foersch Sebastian, Brinker Titus J, Fukuoka Junya, Bychkov Andrey, Uegami Wataru, Truhn Daniel, Brenner Hermann, Brobeil Alexander, Hoffmeister Michael, Kather Jakob Nikol |
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International journal of molecular sciences 2023 3 24 (5): . Martianov Aleksandr S, Mitiushkina Natalia V, Ershova Anastasia N, Martynenko Darya E, Bubnov Mikhail G, Amankwah Priscilla, Yanus Grigory A, Aleksakhina Svetlana N, Tiurin Vladislav I, Venina Aigul R, Anuskina Aleksandra A, Gorgul Yuliy A, Shestakova Anna D, Maidin Mikhail A, Belyaev Alexey M, Baboshkina Liliya S, Iyevleva Aglaya G, Imyanitov Evgeny |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: